Fluigent

Executive Summary

Fluigent is a French company specializing in advanced fluid control systems for microfluidics, a field that manipulates small volumes of fluids for applications in diagnostics, drug delivery, and life sciences research. Founded in 2004 and based in Paris, the company pioneered pressure-based flow control technology, offering researchers and industrial engineers enhanced precision, automation, and ease of use compared to traditional syringe-pump systems. Fluigent's solutions are integral to organ-on-a-chip platforms and droplet-based assays, enabling more accurate modeling of physiological processes and high-throughput screening. As microfluidics gains traction in personalized medicine and pharmaceutical development, Fluigent's established technology positions it well to capitalize on growing demand for reproducible, scalable fluid handling in both academic and industrial settings. The company's long track record and specialization in pressure-based control provide a competitive moat, though its private status and modest size limit visibility into near-term financial performance.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation pressure controller with integrated software automation80% success
• Q2 2027Strategic partnership with a major pharmaceutical company for organ-on-a-chip applications50% success
• Q3 2027Expansion into Asian microfluidics market via distribution agreements60% success